Hydrops Fetalis Secondary to Parvovirus B19 Infections

References

1. 1.↵
   Cossart YE, Field AM, Cant B, Widdows D. Parvovirus-like particles in human sera. Lancet 1975; 1: 72–3.

   OpenUrlPubMedWeb of Science
2. 2.↵
   Anderson MJ, Jones SE, Fisher-Hoch SP, et al. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet 1983; 1: 1378.

   OpenUrl
3. 3.↵
   Brown T, Anand A, Ritchie LD, Clewley JP, Reid TM. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 1984; 2: 1033–4.

   OpenUrl
4. 4.↵
   Knott PD, Welply GA, Anderson MJ. Serologically proved intrauterine infection with parvovirus. Br Med J (Clin Res Ed) 1984; 289: 1660.
5. 5.↵
   Anand A, Gray ES, Brown T, Clewley JP, Cohen BJ. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med 1987; 316: 183–6.

   OpenUrlPubMedWeb of Science
6. 6.
   Risks associated with human parvovirus B19 infections. MMWR Morb Mortal Wkly Rep 1989; 38: 81–8, 93–7.
7. 7.
   Rodis JF, Hovick TJ Jr, Quinn DL, Rosengren SS, Tattersall P. Human parvovirus infection in pregnancy. Obstet Gynecol 1988; 72: 733–8..

   OpenUrlPubMedWeb of Science
8. 8.↵
   Rodis JF, Borgida AF, Wilson M, et al. Management of parvovirus infection in pregnancy and outcomes of hydrops: a survey of members of the Society of Perinatal Obstetricians. Am J Obstet Gynecol 1998; 179: 985–8.

   OpenUrlCrossRefPubMed
9. 9.↵
   Harger JH, Adler SP, Koch WC, Harger GF. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet Gynecol 1998; 91: 413–20.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    Valeur-Jensen AK, Pedersen CB, Westergaard T, et al. Risk factors for parvovirus B19 infection in pregnancy. JAMA 1999; 281: 1099–105.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    Tolfvenstam T, Papadogiannakis N, Norbeck O, Petersson K, Broliden K. Frequency of human parvovirus B19 infection in intrauterine. Lancet 2001; 357: 1494–7.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    Murphy J, Jones DC. Managing the gravida with parvovirus. OBG Manage 2000; Nov: 1–7.
13. 13.↵
    Von Kaisenberg GS, Jonat W. Fetal parvovirus B19 infection. Ultrasound Obstet Gynecol 2001; 18: 280–8.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    Weiland HT, Vermey-Keers C, Salimans MM, Fleuren GJ, Verwey RA, Anderson MJ. Parvovirus B19 associated with fetal abnormality. Lancet 1987; 1: 682–3.

    OpenUrl
15. 15.↵
    Turnquest MA, Brown HL. Human parvovirus B19 infection during pregnancy. Female Patient 1999; 24: 75–81.
16. 16.↵
    Dieck D, Schild RL, Hansmann M, Eis-Hubinger AM. Prenatal diagnosis of congenital parvovirus B19 infection: value of serological and PCR techniques in maternal and fetal serum. Prenat Diagn 1999; 19: 1119–23.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    Bernstein IM, Capeless EL. Elevated maternal serum alpha-fetoprotein and hydrops fetalis in association with fetal parvovirus B19 infection. Obstet Gynecol 1989; 74(3 Pt 2): 456–7.

    OpenUrlPubMed
18. 18.
    Saller DN Jr, Rogers BB, Canick JA. Maternal serum biochemical markers in pregnancies with fetal parvovirus B19 infection. Prenat Diagn 1993; 13: 467–71.

    OpenUrlPubMed
19. 19.
    Carrington D, Gilmore DH, Whittle MJ, et al. Maternal serum alpha-fetoprotein—a marker of fetal aplastic crisis during intrauterine human parvovirus infection. Lancet 1987; 1: 433–5.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    Wiersbitzky SK, Beyersdorff E, Mueller C, et al. Perinatal parvovirus B19 infection: what are the clinical consequences? Pediatr Hematol Oncol 1997; 14: 589–92.

    OpenUrlPubMed
21. 21.↵
    Rodis JF, Rodner C, Hansen AA, et al. Long-term outcome of children following maternal human parvovirus B19 infection. Obstet Gynecol 1998; 91: 125–8.

    OpenUrlPubMed
22. 22.↵
    Crowcroft NS, Roth CE, Cohen BJ, Miller E. Guidance for control of parvovirus B19 infection in healthcare settings and the community. J Public Health Med 1999; 21: 439–46.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    Parvovirus B19. In: Pickering LK, editor. Report of the Committee on Infectious Diseases. 25th ed. 2000 Red book. Evanston, Ill: American Academy of Pediatrics, 2000: 423–5.
24. 24.↵
    Bolyard EA, Tablan OC, Williams WW, et al. Guideline for infection control in health care personnel, 1998. Am J Infect Control 1998; 26: 289–354..